Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

The impact of impaired renal function on mortality in patients with acutely decompensated chronic heart failure.

Vaz Pérez A, Otawa K, Zimmermann AV, Stockburger M, Müller-Werdan U, Werdan K, Schmidt HB, Ince H, Rauchhaus M.

Eur J Heart Fail. 2010 Feb;12(2):122-8. doi: 10.1093/eurjhf/hfp184.

2.

Renal function in outpatients with chronic heart failure.

Waldum B, Westheim AS, Sandvik L, Flønaes B, Grundtvig M, Gullestad L, Hole T, Os I.

J Card Fail. 2010 May;16(5):374-80. doi: 10.1016/j.cardfail.2010.01.001. Epub 2010 Mar 3.

PMID:
20447572
3.

Clinical correlates of hemoconcentration during hospitalization for acute decompensated heart failure.

Davila C, Reyentovich A, Katz SD.

J Card Fail. 2011 Dec;17(12):1018-22. doi: 10.1016/j.cardfail.2011.08.004. Epub 2011 Sep 3.

PMID:
22123365
4.

Worsening of renal function during 1 year after hospital discharge is a strong and independent predictor of all-cause mortality in acute decompensated heart failure.

Ueda T, Kawakami R, Sugawara Y, Okada S, Nishida T, Onoue K, Soeda T, Okayama S, Takeda Y, Watanabe M, Kawata H, Uemura S, Saito Y.

J Am Heart Assoc. 2014 Nov 4;3(6):e001174. doi: 10.1161/JAHA.114.001174.

5.

Worsening renal function in children hospitalized with decompensated heart failure: evidence for a pediatric cardiorenal syndrome?

Price JF, Mott AR, Dickerson HA, Jefferies JL, Nelson DP, Chang AC, O'Brian Smith E, Towbin JA, Dreyer WJ, Denfield SW, Goldstein SL.

Pediatr Crit Care Med. 2008 May;9(3):279-84. doi: 10.1097/PCC.0b013e31816c6ed1.

PMID:
18446113
6.

Effect of digoxin noncompliance on hospitalization and mortality in patients with heart failure in long-term therapy: a prospective cohort study.

Miura T, Kojima R, Mizutani M, Shiga Y, Takatsu F, Suzuki Y.

Eur J Clin Pharmacol. 2001 Apr;57(1):77-83.

PMID:
11372597
7.

Acute kidney injury and outcomes in acute decompensated heart failure: evaluation of the RIFLE criteria in an acutely ill heart failure population.

Hata N, Yokoyama S, Shinada T, Kobayashi N, Shirakabe A, Tomita K, Kitamura M, Kurihara O, Takahashi Y.

Eur J Heart Fail. 2010 Jan;12(1):32-7. doi: 10.1093/eurjhf/hfp169.

8.

Long-term prognosis of combined chronic heart failure and chronic renal dysfunction after acute stroke.

Tsagalis G, Bakirtzi N, Spengos K, Vemmou A, Manios E, Xinos K, Vemmos K.

Eur J Heart Fail. 2010 Aug;12(8):849-54. doi: 10.1093/eurjhf/hfq060. Epub 2010 Apr 22.

9.

A multivariate model for predicting mortality in patients with heart failure and systolic dysfunction.

Brophy JM, Dagenais GR, McSherry F, Williford W, Yusuf S.

Am J Med. 2004 Mar 1;116(5):300-4.

PMID:
14984814
10.

[Differences in clinical profile and outcome in patients with decompensated heart failure and systolic dysfunction or preserved systolic function].

Macín SM, Perna ER, Címbaro Canella JP, Alvarenga P, Pantich R, Ríos N, Farías EF, Badaracco JR.

Rev Esp Cardiol. 2004 Jan;57(1):45-52. Spanish.

11.

[Do we use digitalis properly in the management of elderly patients suffering from the signs of chronic heart failure?].

Erdei F, Vendrey R, Dani G, Kovács E, Márk L, Katona A.

Orv Hetil. 2006 Oct 15;147(41):1993-6. Hungarian.

PMID:
17120690
12.
13.

Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function?

Mullens W, Abrahams Z, Skouri HN, Francis GS, Taylor DO, Starling RC, Paganini E, Tang WH.

J Am Coll Cardiol. 2008 Jan 22;51(3):300-6. doi: 10.1016/j.jacc.2007.09.043.

14.

Sex-based differences in the effect of digoxin for the treatment of heart failure.

Rathore SS, Wang Y, Krumholz HM.

N Engl J Med. 2002 Oct 31;347(18):1403-11.

15.

Early vasoactive drugs improve heart failure outcomes.

Peacock WF, Emerman C, Costanzo MR, Diercks DB, Lopatin M, Fonarow GC.

Congest Heart Fail. 2009 Nov-Dec;15(6):256-64. doi: 10.1111/j.1751-7133.2009.00112.x.

17.

Prognostic impact of sleep disordered breathing and its treatment in heart failure: an observational study.

Jilek C, Krenn M, Sebah D, Obermeier R, Braune A, Kehl V, Schroll S, Montalvan S, Riegger GA, Pfeifer M, Arzt M.

Eur J Heart Fail. 2011 Jan;13(1):68-75. doi: 10.1093/eurjhf/hfq183. Epub 2010 Oct 20.

18.

Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure.

Cohen-Solal A, Logeart D, Huang B, Cai D, Nieminen MS, Mebazaa A.

J Am Coll Cardiol. 2009 Jun 23;53(25):2343-8. doi: 10.1016/j.jacc.2009.02.058.

19.

Renal function, digoxin therapy, and heart failure outcomes: evidence from the digoxin intervention group trial.

Shlipak MG, Smith GL, Rathore SS, Massie BM, Krumholz HM.

J Am Soc Nephrol. 2004 Aug;15(8):2195-203.

20.

Management of acute decompensated heart failure in an evidence-based era: what is the evidence behind the current standard of care?

Fares WH.

Heart Lung. 2008 May-Jun;37(3):173-8. doi: 10.1016/j.hrtlng.2007.05.001. Review.

PMID:
18482628

Supplemental Content

Support Center